Literature DB >> 10862793

Mixed chimerism and tolerance without whole body irradiation in a large animal model.

Y Fuchimoto1, C A Huang, K Yamada, A Shimizu, H Kitamura, R B Colvin, V Ferrara, M C Murphy, M Sykes, M White-Scharf, D M Neville, D H Sachs.   

Abstract

Mixed hematopoietic chimerism may provide a treatment for patients with nonmalignant hematologic diseases, and may tolerize patients to organ allografts without requiring chronic immunosuppression. However, the toxicity of the usual conditioning regimens has limited the clinical applicability of this approach. These regimens generally include some level of whole body irradiation (WBI), which is thought to facilitate engraftment either by making room for donor hematopoietic stem cells or by providing sufficient host immunosuppression to enable donor cells to engraft. Here, we have established mixed chimerism across both minor and major histocompatibility barriers in swine, by using high doses of peripheral blood stem cells in the absence of WBI. After mixed chimerism was established, swine leukocyte antigen-matched (SLA-matched) donor skin grafts were tolerated and maintained for a prolonged period, whereas third-party SLA-matched skin was rejected promptly. Donor-matched kidney allografts were also accepted without additional immunosuppression. Because of its low toxicity, this approach has potential for a wide range of clinical applications. Our data may indicate that niches for engrafting stem cells are filled by mass action and that WBI, which serves to empty some of these niches, can be omitted if the donor inoculum is sufficiently large and if adequate host T-cell depletion is achieved before transplant.

Entities:  

Mesh:

Year:  2000        PMID: 10862793      PMCID: PMC378506          DOI: 10.1172/JCI8721

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Transplantation in miniature swine. VII. Evidence for cellular immune mechanisms in hyperacute rejection of renal alografts.

Authors:  R L Kirkman; R B Colvin; M W Flye; G M Williams; D H Sachs
Journal:  Transplantation       Date:  1979-07       Impact factor: 4.939

2.  Transplantation in miniature swine. I. Fixation of the major histocompatibility complex.

Authors:  D H Sachs; G Leight; J Cone; S Schwarz; L Stuart; S Rosenberg
Journal:  Transplantation       Date:  1976-12       Impact factor: 4.939

3.  Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells.

Authors:  C Dumont; O Déas; B Mollereau; C Hebib; V Giovino-Barry; A Bernard; F Hirsch; B Charpentier; A Senik
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

4.  Transplantation in miniature swine. III: effects of MSLA and A-O blood group matching on skin allograft survival.

Authors:  G S Leight; R Kirkman; B A Rasmusen; S A Rosenberg; D H Sachs; R Terrill; G M Williams
Journal:  Tissue Antigens       Date:  1978-08

5.  Tolerance of Sk-incompatible skin grafts.

Authors:  E A Boyse; E A Carswell; M P Scheid; L J Old
Journal:  Nature       Date:  1973-08-17       Impact factor: 49.962

6.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts.

Authors:  S T Ildstad; D H Sachs
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

7.  A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.

Authors:  C C Soderling; C W Song; B R Blazar; D A Vallera
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

8.  Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine.

Authors:  L R Pennington; J K Lunney; D H Sachs
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

9.  Preparation and characterization of monoclonal antibodies reactive with porcine PBL.

Authors:  M D Pescovitz; J K Lunney; D H Sachs
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

10.  Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone.

Authors:  D A Vallera; C C Soderling; G J Carlson; J H Kersey
Journal:  Transplantation       Date:  1981-03       Impact factor: 4.939

View more
  46 in total

1.  The future of allogeneic hematopoietic stem cell transplantation: minimizing pain, maximizing gain.

Authors:  M T Little; R Storb
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Skin allograft maintenance in a new synchimeric model system of tolerance.

Authors:  N N Iwakoshi; T G Markees; N Turgeon; T Thornley; A Cuthbert; J Leif; N E Phillips; J P Mordes; D L Greiner; A A Rossini
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 3.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

Review 4.  The challenge of immunogenicity in the quest for induced pluripotency.

Authors:  Paul J Fairchild
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

Review 5.  Immuno-intervention for the induction of transplantation tolerance through mixed chimerism.

Authors:  David H Sachs; Megan Sykes; Tatsuo Kawai; A Benedict Cosimi
Journal:  Semin Immunol       Date:  2011-08-11       Impact factor: 11.130

Review 6.  Induction of tolerance through mixed chimerism.

Authors:  David H Sachs; Tatsuo Kawai; Megan Sykes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 7.  Miniature Swine as a Clinically Relevant Model of Graft-Versus-Host Disease.

Authors:  Raimon Duran-Struuck; Christene A Huang; Katherine Orf; Roderick T Bronson; David H Sachs; Thomas R Spitzer
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

8.  Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Authors:  T Kawai; D H Sachs; B Sprangers; T R Spitzer; S L Saidman; E Zorn; N Tolkoff-Rubin; F Preffer; K Crisalli; B Gao; W Wong; H Morris; S A LoCascio; P Sayre; B Shonts; W W Williams; R-N Smith; R B Colvin; M Sykes; A B Cosimi
Journal:  Am J Transplant       Date:  2014-06-05       Impact factor: 8.086

9.  CD40-ligand in primate cardiac allograft and viral immunity.

Authors:  R N Pierson; J E Crowe; S Pfeiffer; J Atkinson; A Azimzadeh; G G Miller
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

10.  Overcoming immunological barriers in regenerative medicine.

Authors:  Johannes L Zakrzewski; Marcel R M van den Brink; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.